Overview

The Effects of Kuvan on Functional Brain Connectivity in Individuals With Phenylketonuria (PKU)

Status:
Completed
Trial end date:
2011-08-01
Target enrollment:
Participant gender:
Summary
The objective of the study is to determine whether Kuvan™ (sapropterin) improves the strength of the functional connectivity between brain regions in individuals with PKU.
Details
Lead Sponsor:
University of Missouri-Columbia
Collaborator:
BioMarin Pharmaceutical
Treatments:
Verapamil